drug

rintatolimod

1 story · latest Aug 11, 2026

Status: Investigational
Trials: 1 registered trial in coverage

Relationships

Developed by AIM ImmunoTech Inc.

Timeline

AIM ImmunoTech CEO ties Ampligen antiviral research to military biodefense in Breaking Defense op-ed

Aug 11PeopleAIM ImmunoTech Inc.

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.